H2CAA71 polynucleotides

Details H2CAA71 polynucleotides H2CAA71 polynucleotides

1997-05-30

1999-01-12

Teng, Sally P.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

536 235, 4352523, 43525411, 4353201, 435325, 4351721, 935 1, C12N 1509, C07K 14705

Patent

active

058587160

ABSTRACT:
Novel 7TM receptor (H2CAA71) polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Novel 7TM receptor (H2CAA71) polypeptides and polynucleotides in the design of protocols for the treatment of infections such as bacterial, fungal, protozoan and viral infections, particularly infections caused by HIV-1 or HIV-2; pain; cancers; anorexia; bulimia; asthna; Parkion's disease; acute heart failure; hypotension; hypertension; uinary retention; osteoporosis; angina pectoris; myocardial infarction; ulcers; asthma; allergies; benign prostatic hypertrophy; and psychotic and neurological disorders, including anxiety, schizophrenia, manic depression, delirium, dementia, severe mental retardation and dyskinesias, such as Huntington's disease or Gilles dela Tourett's syndrome, among others and diagnostic assays for such conditions.

REFERENCES:
George et al., Macromolecular Sequencing and Synthesis, 127-149, 1988, Alan K. Liss, Inc. New York.

Affiliated with

Also associated with

Rating

H2CAA71 polynucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with H2CAA71 polynucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and H2CAA71 polynucleotides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1514301